A phase I-II study of 9-cis retinoic acid and interferon-alpha2b in patients with advanced renal-cell carcinoma: an NCIC Clinical Trials Group study.

W H Miller; L M Reyno; G R Loewen; S Huan; E Winquist; M Moore; A Cato; D Jaunakais; J A Truglia; S Matthews

doi:10.1023/a:1026579400806

A phase I-II study of 9-cis retinoic acid and interferon-alpha2b in patients with advanced renal-cell carcinoma: an NCIC Clinical Trials Group study.

Identifier:nobleid.org/w1/20260515/2CE13253

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2CE13253.svg?ark=w1%2F20260515%2F2CE13253)](https://nobleid.org/work/w1/20260515/2CE13253)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A phase I-II study of 9-cis retinoic acid and interferon-alpha2b in patients with advanced renal-cell carcinoma: an NCIC Clinical Trials Group study.

Identifier:nobleid.org/w1/20260515/2CE13253

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2CE13253.svg?ark=w1%2F20260515%2F2CE13253)](https://nobleid.org/work/w1/20260515/2CE13253)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work